Cost and utility in immunocompromised subjects who developed herpes zoster during the randomized V212 Inactivated Varicella-Zoster Vaccine (ZVIN) trial.

CONCLUSION: Both HZ and PHN are associated with considerable disutility in recipients of auto-HSCT. Costs were comparable to published estimates in other immunocompromised subjects.The trial is registered at ClinicalTrials.gov (CT.gov identifier: NCT01229267). PMID: 31721601 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31721601?dopt=Abstract

Source: Expert Review of Pharmacoeconomics and Outcomes Research - November 15, 2019 Category: Health Management Tags: Expert Rev Pharmacoecon Outcomes Res Source Type: research